Dielectrophoretic trapping of single leukemic cells using the conventional and compact optical measurement systems

Here, we report a microfluidic same‐single‐cell analysis to study the inhibition of multidrug resistance due to drug efflux on single leukemic cells. Drug efflux inhibition was investigated in the microfluidic chip using two different fluorescence detection systems, namely, a compact single‐cell bioanalyzer and the conventional optical detection system constructed from an inverted microscope and a microphotometer. More importantly, a compact signal generator was used to conduct dielectrophoretic cell trapping together with the compact SCB. By using the DEP force, a single acute myeloid leukemia cell was trapped in the cell retention structure of the chip. This allowed us to detect dye accumulation in the MDR leukemic cells in the presence of cyclosporine A (CsA). CsA and rhodamine 123 were used as the P‐glycoprotein inhibitor and fluorescent dye, respectively. The result showed that the Rh123 fluorescence signal in a single‐cell increased dramatically over its same‐cell control on both fluorescence detection systems due to the inhibition by CsA.

[1]  A. Duncan,et al.  Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. , 1992, Science.

[2]  Paul C H Li,et al.  Real-time detection of the early event of cytotoxicity of herbal ingredients on single leukemia cells studied in a microfluidic biochip. , 2009, Integrative biology : quantitative biosciences from nano to macro.

[3]  U. Germann,et al.  P-glycoprotein--a mediator of multidrug resistance in tumour cells. , 1996, European journal of cancer.

[4]  Dawei Xu,et al.  Different effects of metabolic inhibitors and cyclosporin A on daunorubicin transport in leukemia cells from patients with AML. , 2003, Leukemia research.

[5]  Kun Li,et al.  TanshinoneIIA enhances the chemosensitivity of breast cancer cells to doxorubicin through down-regulating the expression of MDR-related ABC transporters. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[6]  P. J. Russell,et al.  Label-free isolation of a prostate cancer cell among blood cells and the single-cell measurement of drug accumulation using an integrated microfluidic chip. , 2015, Biomicrofluidics.

[7]  H. Landau,et al.  The farnesyl transferase inhibitor, tipifarnib, is a potent inhibitor of the MDR1 gene product, P-glycoprotein, and demonstrates significant cytotoxic synergism against human leukemia cell lines , 2007, Leukemia.

[8]  T. Tsuruo,et al.  Clinical significance of multidrug resistance P-glycoprotein expression on acute nonlymphoblastic leukemia cells at diagnosis. , 1992, Blood.

[9]  T. Ozben Mechanisms and strategies to overcome multiple drug resistance in cancer , 2006, FEBS letters.

[10]  I. Pastan,et al.  Most drugs that reverse multidrug resistance also inhibit photoaffinity labeling of P-glycoprotein by a vinblastine analog. , 1988, Molecular pharmacology.

[11]  A. Yu,et al.  ABC transporters in multidrug resistance and pharmacokinetics, and strategies for drug development. , 2014, Current pharmaceutical design.

[12]  Zhe-Sheng Chen,et al.  Dacomitinib antagonizes multidrug resistance (MDR) in cancer cells by inhibiting the efflux activity of ABCB1 and ABCG2 transporters. , 2018, Cancer letters.

[13]  H. Coley,et al.  Overcoming multidrug resistance in cancer: an update on the clinical strategy of inhibiting p-glycoprotein. , 2003, Cancer control : journal of the Moffitt Cancer Center.

[14]  Xiujun Li,et al.  Microfluidic selection and retention of a single cardiac myocyte, on-chip dye loading, cell contraction by chemical stimulation, and quantitative fluorescent analysis of intracellular calcium. , 2005, Analytical chemistry.

[15]  Bin Wang,et al.  Co-loading of photothermal agents and anticancer drugs into porous silicon nanoparticles with enhanced chemo-photothermal therapeutic efficacy to kill multidrug-resistant cancer cells. , 2018, Colloids and surfaces. B, Biointerfaces.

[16]  K. Kohno,et al.  A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation. , 1996, Cancer research.

[17]  M. Khoshayand,et al.  Dual drug delivery system of PLGA nanoparticles to reverse drug resistance by altering BAX/Bcl-2 , 2018, Journal of Drug Delivery Science and Technology.

[18]  Feng Shen,et al.  Study of flow behaviors on single-cell manipulation and shear stress reduction in microfluidic chips using computational fluid dynamics simulations. , 2014, Biomicrofluidics.

[19]  J. O'Brien,et al.  Combining cyclosporin with chemotherapy controls intraocular retinoblastoma without requiring radiation. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

[20]  Myung Soo Kim,et al.  Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells. , 2016, Nanomedicine : nanotechnology, biology, and medicine.

[21]  Richard M Maceiczyk,et al.  Small but Perfectly Formed? Successes, Challenges, and Opportunities for Microfluidics in the Chemical and Biological Sciences , 2017 .

[22]  J. Dou,et al.  Downregulation of gene MDR1 by shRNA to reverse multidrug-resistance of ovarian cancer A2780 cells. , 2012, Journal of cancer research and therapeutics.

[23]  Helene Andersson-Svahn,et al.  Overview of single-cell analyses: microdevices and applications. , 2010, Lab on a chip.

[24]  F. Sharom ABC multidrug transporters: structure, function and role in chemoresistance. , 2008, Pharmacogenomics.

[25]  A. Benito,et al.  A cytotoxic ribonuclease reduces the expression level of P-glycoprotein in multidrug-resistant cell lines , 2012, Investigational New Drugs.

[26]  Paul C H Li,et al.  A simple and fast microfluidic approach of same-single-cell analysis (SASCA) for the study of multidrug resistance modulation in cancer cells. , 2011, Lab on a chip.

[27]  M. Gottesman,et al.  Drug resistance: still a daunting challenge to the successful treatment of AML. , 2012, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[28]  Lei Zhang,et al.  Design, synthesis and antineoplastic activity of novel hybrids of podophyllotoxin and indirubin against human leukaemia cancer cells as multifunctional anti-MDR agents. , 2018, Bioorganic & medicinal chemistry letters.

[29]  Elinore M Mercer,et al.  Microfluidic sorting of mammalian cells by optical force switching , 2005, Nature Biotechnology.

[30]  T. Fojo,et al.  ABC Transporters: Involvement in Multidrug Resistance and Drug Disposition , 2014 .

[31]  M. Gandhi,et al.  Dielectrophoretic Microfluidic Chip Enables Single-Cell Measurements for Multidrug Resistance in Heterogeneous Acute Myeloid Leukemia Patient Samples. , 2016, Analytical chemistry.

[32]  A. Tsatsakis,et al.  Resveratrol as MDR reversion molecule in breast cancer: An overview. , 2017, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[33]  T. Kroll,et al.  Monitoring the response of circulating epithelial tumor cells to adjuvant chemotherapy in breast cancer allows detection of patients at risk of early relapse. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  Xiujun Li,et al.  Real‐time monitoring of intracellular calcium dynamic mobilization of a single cardiomyocyte in a microfluidic chip pertaining to drug discovery , 2007, Electrophoresis.

[35]  Zhe-Sheng Chen,et al.  Suppression of ABCG2 mediated MDR in vitro and in vivo by a novel inhibitor of ABCG2 drug transport , 2017, Pharmacological research.

[36]  S. Cole,et al.  Characterization of vincristine transport by the M(r) 190,000 multidrug resistance protein (MRP): evidence for cotransport with reduced glutathione. , 1998, Cancer research.

[37]  E. Wang,et al.  In vitro flow cytometry method to quantitatively assess inhibitors of P-glycoprotein. , 2000, Drug metabolism and disposition: the biological fate of chemicals.

[38]  B. Hirst,et al.  The ABCs of drug transport in intestine and liver: efflux proteins limiting drug absorption and bioavailability. , 2004, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[39]  R. Jonker,et al.  Effect of cyclosporin A on daunorubicin accumulation in multidrug-resistant P388 leukemia cells measured by real-time flow cytometry , 2004, Cancer Chemotherapy and Pharmacology.

[40]  C. Higgins,et al.  Multiple molecular mechanisms for multidrug resistance transporters , 2007, Nature.

[41]  Paul C H Li,et al.  Same-single-cell analysis using the microfluidic biochip to reveal drug accumulation enhancement by an amphiphilic diblock copolymer drug formulation , 2014, Analytical and Bioanalytical Chemistry.